» Articles » PMID: 33936281

Chemical Hemorrhagic Cystitis: Diagnostic and Therapeutic Pitfalls (Review)

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2021 May 3
PMID 33936281
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Chemical cystitis (CC) is an inflammation of the bladder caused by various chemical agents ingested intentionally or accidentally. It is linked to chemotherapeutic agents such as cyclophosphamide, therapeutic agents for diverse diseases, and anesthetic agents consumed abusively for recreational effects such as ketamine, or can be linked to environmental and surrounding factors such as soaps, gels, spermicides, and dyes. CC is a pathology with an increasing incidence that is inadequately treated due to its infectious cystitis-like symptoms. The hemorrhagic form can have a rampant evolution. Treatment options of CC and its complications are under continuous research with no accepted standardized sequence. In many situations, the treatments are difficult to obtain, administer, and follow-up. In addition, the lack of experience of the physician may pose other obstacles in delivering treatment to the patient. In conclusion, CC is a disease with an increasing incidence, challenging to diagnose, which is frequently mistreated, and has multiple treatment modalities that still require standardization in administration and sequencing.

Citing Articles

Dimethyl Fumarate Attenuates Cyclophosphamide-Induced Bladder Damage and Enhances Cytotoxic Activity Against SH-SY5Y Cells.

Barut E, Engin S, Oz E, Reis R J Biochem Mol Toxicol. 2025; 39(3):e70212.

PMID: 40059813 PMC: 11891824. DOI: 10.1002/jbt.70212.


Comparison of treatments for preventing lower urinary tract symptoms after BCG immunotherapy of bladder tumors : a systematic review and network meta-analysis.

Chen Z, Chen X, Li D, Jian J, Yao C, Wei X BMC Urol. 2025; 25(1):19.

PMID: 39875945 PMC: 11776312. DOI: 10.1186/s12894-024-01675-6.


Quality by design approach of apocynin loaded clove oil based nanostructured lipid carrier as a prophylactic regimen in hemorrhagic cystitis in vitro and in vivo comprehensive study.

Maghrabia A, Boughdady M, Khater S, Abu Hashim I, Meshali M Sci Rep. 2024; 14(1):19162.

PMID: 39160172 PMC: 11333711. DOI: 10.1038/s41598-024-68721-z.


Slightly photo-crosslinked chitosan/silk fibroin hydrogel adhesives with hemostasis and anti-inflammation for pro-healing cyclophosphamide-induced hemorrhagic cystitis.

Yao J, Chen Y, Zhang X, Chen J, Zhou C, Jiang J Mater Today Bio. 2024; 25:100947.

PMID: 38298562 PMC: 10826334. DOI: 10.1016/j.mtbio.2024.100947.


Lower Urinary Tract Disorders as Adverse Drug Reactions-A Literature Review.

Dobrek L Pharmaceuticals (Basel). 2023; 16(7).

PMID: 37513941 PMC: 10383968. DOI: 10.3390/ph16071031.


References
1.
Kim S, Koh D, Park J, Ahn H, Choi J, Kim Y . Hemorrhagic cystitis due to intravesical instillation of gentian violet completely recovered with conservative therapy. Yonsei Med J. 2003; 44(1):163-5. DOI: 10.3349/ymj.2003.44.1.163. View

2.
Das S . Natural therapeutics for urinary tract infections-a review. Futur J Pharm Sci. 2020; 6(1):64. PMC: 7498302. DOI: 10.1186/s43094-020-00086-2. View

3.
Buchbinder R, Forbes A, Kobben F, Boyd I, Snow R, McNeil J . Clinical features of tiaprofenic acid (surgam) associated cystitis and a study of risk factors for its development. J Clin Epidemiol. 2000; 53(10):1013-9. DOI: 10.1016/s0895-4356(00)00192-x. View

4.
Trotman J, Nivison-Smith I, Dodds A . Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration. Bone Marrow Transplant. 1999; 23(8):797-801. DOI: 10.1038/sj.bmt.1701644. View

5.
Martin-Suarez I, DCruz D, Mansoor M, Fernandes A, Khamashta M, Hughes G . Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide. Ann Rheum Dis. 1997; 56(8):481-7. PMC: 1752422. DOI: 10.1136/ard.56.8.481. View